20 Sep 2016
LIBERUM: Shield Therapeutics – Positive H1 results; first UK revenues and strong DE price
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
LIBERUM: Shield Therapeutics – Positive H1 results; first UK revenues and strong DE price
Shield Therapeutics Plc (STX:LON) | 1.3 0 0.0% | Mkt Cap: 10.4m
- Published:
20 Sep 2016 -
Author:
Roger Franklin -
Pages:
3